Owens & Minor (NYSE:OMI) PT Raised to $28.00 at Robert W. Baird

Owens & Minor (NYSE:OMI) had its target price boosted by stock analysts at Robert W. Baird from $24.00 to $28.00 in a research note issued on Wednesday, Benzinga reports. The firm currently has a “neutral” rating on the stock. Robert W. Baird’s price target suggests a potential upside of 7.94% from the stock’s current price.

OMI has been the topic of a number of other research reports. Leerink Partnrs restated a “market perform” rating on shares of Owens & Minor in a research note on Monday, February 26th. Citigroup lifted their price objective on shares of Owens & Minor from $23.00 to $24.00 and gave the company a “neutral” rating in a research report on Wednesday, February 21st. StockNews.com upgraded shares of Owens & Minor from a “hold” rating to a “buy” rating in a research report on Wednesday, February 21st. SVB Leerink began coverage on shares of Owens & Minor in a research report on Monday, February 26th. They set a “market perform” rating and a $24.00 price objective on the stock. Finally, Barclays lifted their price objective on shares of Owens & Minor from $21.00 to $23.00 and gave the company an “equal weight” rating in a research report on Wednesday, February 21st. One analyst has rated the stock with a sell rating, six have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $23.29.

Owens & Minor Price Performance

NYSE OMI opened at $25.94 on Wednesday. Owens & Minor has a 12 month low of $13.34 and a 12 month high of $28.35. The stock has a market cap of $1.99 billion, a price-to-earnings ratio of -48.04, a PEG ratio of 0.86 and a beta of 0.43. The company’s 50 day moving average is $24.35 and its two-hundred day moving average is $20.44. The company has a current ratio of 1.11, a quick ratio of 0.52 and a debt-to-equity ratio of 2.05.

Owens & Minor (NYSE:OMI) last released its earnings results on Tuesday, February 20th. The company reported $0.69 EPS for the quarter, topping analysts’ consensus estimates of $0.66 by $0.03. Owens & Minor had a negative net margin of 0.40% and a positive return on equity of 11.62%. The company had revenue of $2.66 billion for the quarter, compared to analysts’ expectations of $2.67 billion. During the same quarter last year, the business earned $0.28 EPS. The firm’s revenue was up 4.1% compared to the same quarter last year. As a group, research analysts anticipate that Owens & Minor will post 1.54 earnings per share for the current year.

Insider Buying and Selling

In other Owens & Minor news, SVP Jonathan A. Leon sold 7,500 shares of Owens & Minor stock in a transaction on Wednesday, January 17th. The shares were sold at an average price of $18.08, for a total transaction of $135,600.00. Following the completion of the transaction, the senior vice president now directly owns 83,213 shares of the company’s stock, valued at $1,504,491.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other Owens & Minor news, SVP Jonathan A. Leon sold 7,500 shares of Owens & Minor stock in a transaction on Wednesday, January 17th. The shares were sold at an average price of $18.08, for a total transaction of $135,600.00. Following the completion of the transaction, the senior vice president now directly owns 83,213 shares of the company’s stock, valued at $1,504,491.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Michael Wayne Lowry sold 10,000 shares of Owens & Minor stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $25.00, for a total transaction of $250,000.00. Following the transaction, the senior vice president now directly owns 71,654 shares of the company’s stock, valued at $1,791,350. The disclosure for this sale can be found here. 2.62% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of OMI. Invesco Ltd. grew its holdings in shares of Owens & Minor by 12.0% in the third quarter. Invesco Ltd. now owns 1,081,460 shares of the company’s stock worth $17,476,000 after purchasing an additional 115,995 shares during the last quarter. First Eagle Investment Management LLC bought a new position in shares of Owens & Minor in the third quarter worth about $2,795,000. Gotham Asset Management LLC grew its holdings in shares of Owens & Minor by 106.4% in the third quarter. Gotham Asset Management LLC now owns 33,578 shares of the company’s stock worth $543,000 after purchasing an additional 17,310 shares during the last quarter. Qube Research & Technologies Ltd grew its holdings in shares of Owens & Minor by 95.1% in the third quarter. Qube Research & Technologies Ltd now owns 200,739 shares of the company’s stock worth $3,244,000 after purchasing an additional 97,847 shares during the last quarter. Finally, Gabelli Funds LLC bought a new position in shares of Owens & Minor in the third quarter worth about $1,899,000. 98.04% of the stock is owned by hedge funds and other institutional investors.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.